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HIV/AIDSThe human polyomavirus BK virus (BKV) is an important opportunistic pathogen whose disease prevalence
continues to increase with the growing immunocompromised population. To date, the major determinant of
replication in cell culture has not been formally proven. BKV exists as archetype virus and rearranged variants,
which are classiﬁed based on the DNA sequence of their non-coding control regions (NCCRs). The archetype
BKV NCCR is divided into ﬁve blocks of sequence and rearranged variants contain deletions and duplications
of these blocks. In this study, a genetic system was developed and used to identify the major determinant of
replication ability in primary renal proximal tubule epithelial cells, the natural host cell of BKV. This system
was also used to analyze NCCR variants isolated from an immunocompromised patient which contain
assorted rearrangement patterns and functional differences. This study solidiﬁes the NCCR as the major
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BK virus (BKV) is a highly prevalent human polyomavirus
originally isolated from the urine of a renal transplant patient with
ureteric obstruction (Gardner et al., 1971). BKV is believed to be
spread asymptomatically by a respiratory route, based on evidence
that seroconversion takes place in early childhood and that BKV has
been detected in tonsillar and salivary gland tissues (Goudsmit et al.,
1982; Jeffers et al., 2009). However, data also suggest that a fecal–oral
route of transmission may be possible (Vanchiere et al., 2005a, 2009;
Wong et al., 2009). The seroprevalence of BKV in the population is
reached by the age of 10 and is estimated to be between 65% and 90%
(Kean et al., 2009; Knowles, 2006). Following primary infection, BKV
establishes a lifelong, persistent, subclinical infection in the urinary
tract (Chesters et al., 1983; Heritage et al., 1981). Renal tubule
epithelial cells are a major site in which BKV persists and can be
reactivated (Knowles, 2001; Moens and Rekvig, 2001). BKV is notknown to cause disease in healthy, immunocompetent people, but it
can be periodically isolated from their urine as a result of transient
reactivation events (Knowles, 2001). In some clinical settings, BKV
can reactivate and cause diseases such as hemorrhagic cystitis (HC) in
bone marrow transplant patients and polyomavirus-associated
nephropathy (PVAN) in kidney transplant patients. BKV can also
reactivate in other immunosuppressed populations such as pregnant
women and patients with HIV/AIDS (Doerries, 2006). Studies have
shown both increased incidence and amount of virus present in the
urine of HIV-infected patients as compared to uninfected people
(Knowles et al., 1999; Markowitz et al., 1993). Although rare, BKV
infection in HIV/AIDS patients can result in death (Cubukcu-
Dimopulo et al., 2000).
BKV has a small double-stranded circular DNA genome that is
divided into three genetic regions: the early coding region, the late
coding region, and the non-coding control region (NCCR). BKV is
classiﬁed into archetype virus and rearranged variants based on the
structure of the NCCR, which contains the origin of DNA replication
and promoters for both the early and late coding regions. Archetype
BKV is characterized by ﬁve blocks of DNA sequence within the NCCR:
O, P, Q, R, and S (Fig. 1A). The O block contains the origin of replication
and putative transcription factor binding sites. Rearranged variants of
BKV are characterized by deletions and duplications in the sequence
blocks that enhance replication ability of the virus and allow it to grow
readily in cell culture. The early and late gene promoters and
Fig. 1. The NCCR determines replication efﬁciency of BKV. (A) Schematic of the swap genomewith the archetype virus (Dik) NCCR. SpeI and SacII sites were inserted into the pBR322-
Dunlop or -Dik vectors ﬂanking the majority of the NCCR and a PmlI site was inserted between the early and late regions. (B) RPTE cells were transfected with recircularized viral
genome and low molecular weight DNA was harvested 5 dpt. Samples were linearized, digested with DpnI, and analyzed by Southern blotting. The left panel shows Dik and Dunlop
wt replication compared to the swap vectors containing the three inserted restriction enzyme sites, Dik3 and Dun3 respectively. The right panel shows all possible swap
combinations. Each construct is designated by a three letter abbreviation. A=archetype and R=rearranged. The ﬁrst letter denotes the NCCR; second letter, early region; third
letter, late region. Marker, HindIII digest of pGEM-TU; Mock, mock transfection.
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located in the P, Q, R, and S blocks (Markowitz and Dynan, 1988;
Moens et al., 1995; Moens and Van Ghelue, 2005). BKV archetype
virus can be isolated from both healthy individuals and diseased
patients, and it currently cannot be grown in cell culture. Rearranged
variants are most commonly isolated from patients with BKV diseases
such as PVAN and HC, but not in all such patients, and replicate
robustly in culture.
Previous studies have shown that when archetype virus, isolated
directly from patient urine, is passaged for prolonged periods in cell
culture, it accumulates rearrangements in the NCCR (Rubinstein et al.,
1991). Likewise, although the archetype virus is the prevalent form of
BKV, when high titers of virus are present in the serum of a patient
with BKV disease, the appearance of rearranged variants increases and
these eventually replace archetype as the predominant form of the
virus (Gosert et al., 2008). This is likely due to increased replication
efﬁciency of rearranged variants, resulting in the ability to outcom-
pete archetype virus in an immunocompromised host. The dominance
of rearranged variants in a hostmay directly relate to clinical outcome,
since these variants are able to replicate more efﬁciently and show
increased cytopathology in vitro (Gosert et al., 2008). A recent study
showed that multiple rearranged quasispecies can be found in the
urine or allograft biopsies of kidney transplant recipients, even within
a single patient (Olsen et al., 2009). In addition to differences in the
NCCRs between archetype virus and rearranged variants, it is possible
that polymorphisms in the early and late coding regions can also
contribute to replication ability. Comparing the Dik archetype virus
(Goudsmit et al., 1981) and the Dunlop rearranged variant (Seif et al.,
1979), for example, there are four amino acid differences in the early
coding region: three in TAg and one in tAg. There also are nine amino
acid differences in the late coding region: three in VP1 and six in VP2,
three of which overlap in VP3. However, contributions of the NCCR,
the early and late coding regions to replication have not been
systematically examined.
For the present study, a swap vector system was developed to
resolve the major determinants of BKV replication in primary renal
proximal tubule epithelial (RPTE) cells. This system allows for
independent analysis of the major viral DNA functional regions, the
NCCR and the early and late coding regions, from different BKV
isolates. Using this system, we were able to formally prove that the
NCCR is the major determinant of replication in cell culture. The swap
vector system was then used to functionally analyze variants isolated
from the urine of an AIDS patient with BKV viruria. These clones
displayed a series of NCCR rearrangements with variable levels ofreplication ability and infectious progeny production. These studies
provide a useful genetic systemwith which to analyze patient isolates
and dissect speciﬁc determinants of BKV replication.
Results
The NCCR is sufﬁcient to determine replication ability in cell culture
BKV variants with rearranged NCCRs are able to replicate in cell
culture while viruses with an archetype NCCR are unable to do so. To
determine whether other regions of the BKV genome contribute to
replication ability, we created a swap vector system that allows for the
exchange of the early coding region, late coding region and the NCCR
between archetype virus and rearranged variants (Fig. 1A). Unique
restriction sites were introduced into the archetype (Dik) and
rearranged (Dunlop) variant genomes to create the swap vectors
and investigate the contributions of the three regions to the
replication ability in RPTE cells. SpeI and SacII sites were introduced
into regions with no sequence variation between Dik and Dunlop in
the O block and the S block, respectively, ﬂanking the majority of the
NCCR. Additionally, a PmlI site was inserted between the early and late
regions in both the archetype and rearranged genome in a pBR322
backbone (Seif et al., 1979). The swap vectors were named Dik-3-site
(Dik3), and Dunlop-3-site (Dun3), in reference to the insertion of the
three restriction sites. Using these vectors, we constructed all possible
combinations of the three regions of the archetype virus and
rearranged variants. We were then able to assay replication ability
by a DpnI resistance assay, which distinguishes methylated trans-
fected plasmid DNA that has not been replicated in eukaryotic cells
from unmethylated DNA that has been replicated in eukaryotic cells
(Pipas et al., 1983).
Each recombinant genome was excised from the plasmid, re-
circularized, and transfected into RPTE cells. At 5 days post-transfec-
tion, low molecular weight DNA was isolated (Hirt, 1967), linearized,
digested with DpnI, and assayed by Southern blotting (Fig. 1B). The
exogenous restriction sites had no impact on the replication ability of
the genome (compare lanes 3 to 4 and lanes 5 to 6). Only those
recombinants created containing the rearranged variant NCCR were
able to replicate efﬁciently (lanes 8, 9, and 11) as compared to
recombinants containing the archetype NCCR (lanes 7, 10, and 12). Of
note, a low level of archetype replication was seen in lanes 3, 4, 7, 10,
and 12; however no infectious progenywere detected by an infectious
unit assay (Fig. 3C and data not shown). What appears to be low level
archetype virus replication could have been the result of incomplete
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the major determinant of the ability to replicate in RPTE cells.
Characterization of BKV NCCR variants isolated from an
immunocompromised patient
To test the utility of this system for analyzing patient isolates, we
cloned the BKV NCCR from a urine sample of an AIDS patient with BKV
viruria. The serum and the urine of this patient were tested for the
presence of BKV and JCV by quantitative PCR as previously described
(McNees et al., 2005). JCV was not detected in either ﬂuid and BKV
was only detected in the urine, at 150 genomes/ml. The BKV
amplicons from the patient were sequenced and classiﬁed as
genotype Ia based on VP1 polymorphisms (Jin et al., 1993; Zheng
et al., 2007). We were able to isolate ﬁve distinct NCCRs from this
single urine specimen displaying differing degrees of rearrangement
(Fig. 2A). These clones were designated TCH for their location of
isolation (Texas Children's Hospital) and numbered 1–5. Clones TCH3
and TCH4 have a partial P block inserted before a complete P block,
and differ from each other by the presence of a point mutation. Clones
TCH1 and TCH2 each have unique truncations in their R blocks. In
addition, TCH1 is completely missing the S block. The most highly
rearranged clone, TCH5, contains a partial duplication of both the P
and the Q blocks inserted between the full P and Q blocks. All ﬁve also
have a single nucleotide polymorphism in the O block as compared to
both Dik and Dunlop.
We ﬁrst assessed the replication ability of each isolate by
introducing the restriction enzymes SpeI and SacII into the NCCR of
each variant and then swapping them into the Dun3 backbone. All
genomes were excised from the plasmid backbone, re-circularized,
and transfected into RPTE cells. Four days post-transfection, low
molecular weight DNAwas isolated and assayed for replication ability
by Southern blotting (Fig. 3A). Day 4 was chosen because parental
rearranged variant viral replication can be easily detected at this time
point (data not shown). To quantify replication ability, the replicated
genome band was normalized to a DpnI-digested input band (Fig. 3A,Fig. 2. (A) Schematic of the NCCRs of viruses isolated from a single clinical specimen.
The NCCR is divided into blocks of sequence O, P, Q, R, and S. The block structures of the
archetype virus (Dik), the rearranged variant (Dun), and the variants isolated from the
patient are shown. The * represents the O block polymorphism and the † represents
other mutations relative to the archetype P block sequence. The P′ and P″ blocks of
Dunlop are variations of the P block. (B) A schematic of the Dik C65T and TCH2 T65C
mutants created by site directed mutagenesis.arrow) to control for transfection efﬁciency and the archetype virus
(Dik3) was set to one (Fig. 3B). The clones show various genome
replication abilities ranging from low and intermediate (TCH1, TCH3,
TCH4, TCH2) to high (TCH5), which replicated to levels similar to
Dun3.
To further characterize these patient isolates, infectious progeny
production was assessed using an infectious unit assay as previously
described (Low et al., 2004). Each recombinant genome was
transfected as described above and cell lysates were harvested
seven days post-transfection. Progeny production followed the same
trend as replication, with low and intermediate level replicating
clones producing less progeny than the high level replicating clone
(Fig. 3C). These data indicate that NCCR rearrangements are able to
account for functional differences assayed in vitro.
Finally, we determined whether the O block polymorphism (C65T,
where 1 is the O block starting position) affected replication. Site-
directed mutagenesis was used to recreate the polymorphism
common to all the patient variants in an archetype virus background
(Fig. 2B). Additionally this polymorphism was reverted to the Dik
sequence in a TCH2 background. Replication ability was assessed by
DpnI resistance assay as above. Results from this assay show that the
point mutation does not affect the replication ability of the viruses
(Fig. 4).Discussion
The determinants that regulate the ability of archetype virus and
rearranged variants of BKV to replicate in cell culture have not yet been
systematically mapped. In human embryonic kidney and adult human
skin ﬁbroblast cells, prolonged passage of archetype virus results in the
accumulation of NCCR rearrangements leading to increased replication
ability (Rubinstein et al., 1991). Thus, the NCCR was assumed to be the
main determinant of viral replication based on the data that rearrange-
ments are apparently selected for in cell culture; however, this research
was performed in cells that are not the natural host of BKV infection.
Furthermore the dependence of replication ability on the NCCR has not
previously been directly proven. Additionally, there is suggestive
evidence for the contribution of the early and late coding regions in
regulating polyomavirus replication ability. For example, a naturally
occurringQ169Lmutation in the BKV large tumor antigen (TAg) protein
has been proposed to stabilize its binding to DNA, which could
conceivably affect replication ability since TAg stimulates viral replica-
tion (Smith et al., 1998). Of note, this mutation is not present in either
the Dik or Dunlop viruses used in the present study.
In this study, we showed directly that the NCCR is the major
determinant of BKV replication in cell culture. To answer the question
of which region determines viral replication ability, we developed a
swap vector system. This allowed us to create recombinants of the
archetype virus and rearranged variant genomes to assess the roles of
the NCCR, early coding region, and late coding region in replication.
Insertion of restriction enzyme sites between the regions of the
genome did not affect replication. We then used this vector system
and demonstrated that the NCCR is the major determinant of viral
replication ability in RPTE cells because only those recombinants
containing a rearranged variant NCCR were able to replicate
efﬁciently. This result seems logical considering that the NCCR, early
and late coding regions all have functions that are required for viral
replication, but the early and late coding regions are more genetically
constrained. For example, genetic instability in TAg would be
problematic because it needs to be able to bind the origin in the
NCCR to initiate replication (Eichman and Fanning, 2004). TAg also
has many other functions that require interaction with host proteins,
suggesting that the TAg sequence needs to be stable to maintain these
interactions. The same restrictions may be seen for the late coding
region since the capsid is a relatively rigid structure whose main
Fig. 3. Clones isolated from a clinical specimen display variable replication abilities. RPTE cells were transfected with recircularized viral genomes. (A, B) Lowmolecular weight DNA
was harvested 4 dpt and analyzed as in Fig. 1. (A). Representative Southern blot. The two panels are different exposures of the same blot. Arrow indicates the DpnI-digested band
used for normalization among samples. Mock, mock transfection. (B) Quantiﬁcation of replication data from three independent experiments, error bars represent standard error of
the mean. (C) Viral lysates were prepared from parallel transfections at 7 dpt and assayed for infectious progeny as described in Materials and methods. Results are from three
independent experiments, error bars represent standard error of the mean. The * represents a measurement below the limit of detection.
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host gangliosides for entry into the cell (Low et al., 2006).
We used the swap vector system to analyze BKV NCCRs cloned
directly from a single urine specimen from an AIDS patient with BKV
viruria. The NCCRs of ﬁve distinct isolates with various rearrange-
ments were introduced into the Dunlop background in order to
analyze replication ability and infectious progeny production. All ﬁve
clones were able to replicate better than the archetype virus, Dik, and
each contained at least partial duplications or deletions in the NCCR
sequence blocks. In general, the isolates that had a greater degree of
rearrangements had higher replication ability and infectious progeny
production than those with fewer rearrangements. However, with
such a small sample size it was difﬁcult to discern a clear pattern of
whole or partial block rearrangements that correlated to replication
ability. Clones TCH3 and TCH4 differed by only a point mutation in the
P block and displayed similar functional proﬁles. There was noFig. 4. The O block polymorphism does not affect replication ability. The C65T mutation
was created and reversed in the O blocks of Dik3 and TCH2, respectively, and the
genomes were assayed as in Fig. 3A. The blot is representative of two independent
repeats, and the two panels are different exposures of the same blot. Marker: HindIII
digest of pGEM7-TU (size of bands in kb); Mock, mock transfection.archetype virus isolated from this patient's urine but this does not
conﬁrm its absence: due to the limits of PCR-based assay detection,
only the most highly represented variants are likely to be detected.
The absence of archetype virus from this patient's urine sample may
indicate the severity of the patient's immunocompromised state,
however. The presence of rearranged BKV variants in serum is
associated with increased replication and inﬂammation (Gosert et al.,
2008). While virus excreted in the urine may be produced at a
different site of replication, it may still follow the same trend as the
virus found in the serumwith respect to clinical severity. Additionally,
the HIV-1 Tat protein is able to activate the BKV early promoter in
trans through sites located in the NCCR (Gorrill et al., 2006). This
activation increases TAg expression and therefore, viral DNA
replication. This is another possible factor inﬂuencing the reactivation
of BKV in HIV-infected patients.
Further study is needed to determine why rearranged variants,
and not archetype virus, are able to replicate in cell culture. Archetype
BKV is more frequently isolated from patients than rearranged
variants, but there are no reports of successfully culturing this form.
It is possible that archetype virus and rearranged variants naturally
replicate in separate populations of cells in the host, such that
proximal tubule cells are permissive to rearranged variants but not
archetype virus. Another possible, but not mutually exclusive,
explanation is that the presence or absence of certain transcription
factor binding sites in the NCCR of rearranged variants is required for
replication in tissue culture. We were unable to identify any obvious
pattern contributing to replication ability from an analysis of the
variant NCCRs in comparison to the archetype virus using a
transcription factor binding site prediction program, AliBaba2.1 (see
http://www.gene-regulation.com/pub/programs.html).
In addition to NCCR rearrangements affecting viral gene transcrip-
tion, it is possible that there are direct effects on DNA replication of
the virus. It has been shown that there are three TAg binding sites
within the SV40 regulatory region (i.e., the SV40 NCCR) that are
assumed to be present in the BKV NCCR as well (Del Vecchio et al.,
1989; Yang and Wu, 1979). Rearrangements in the SV40 regulatory
region affect the binding stability of TAg to these sites, altering the
DNA conformation and the levels of DNA replication (Wilderman
et al., 1999). Also, cis-acting sequence elements in mouse polyoma-
virus and SV40 are involved in the activation of replication (de Villiers
et al., 1984; O'Connor and Subramani, 1988; Tang et al., 1987).
Although the O block polymorphism C65T, which is located in
putative TAg binging site I, is present in all of the BKV variants in
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ability. We can use the swap vector system in the future to further
characterize the role of the rearranged NCCR by dissecting its
contribution to transcription and replication.
Materials and methods
Patient and sample collection
Urine specimens were collected periodically from subjects
enrolled in a prospective study of polyomavirus excretion in the
urine of immune compromised patients. The study protocol was
approved by the Institutional Review Board for Human Subjects
Research at Baylor College of Medicine. Informed consent and assent,
when appropriate, was obtained from subjects prior to specimen
collection in 2001. The specimens in this report are from a single
patient.
Cell culture
Primary human RPTE cells were maintained for up to six passages
in renal epithelial growth medium as previously described (Abend
et al., 2007). Infectious unit assays were performed as previously
described (Low et al., 2004).
Plasmids
The pBR322-Dunlop plasmid (ATCC #45025, pBKV) was received
from Peter Howley (Seif et al., 1979). The pBR322-Dik plasmid was
received from John Lednicky. Both of these genomes are inserted into
the pBR322 backbone at the BamHI site. Site-directed mutagenesis
was performed using the QuikChange II Site-Directed Mutagenesis Kit
(Stratagene) as described previously (Abend and Imperiale, 2008) on
both pBR322-Dik and Dunlop to create Dik-3-site (Dik3) and Dunlop-
3-site (Dun3) swap vectors. The SpeI site was inserted into the O block
using primer A and its reverse complement and the SacII site was
inserted using primer B and its reverse complement (Table 1). The
PmlI site was inserted between the early and late regions using primer
C and its reverse complement. Swap combinations were created by
digesting 10 μg of Dik3 and Dun3 with the appropriate restriction
enzymes to obtain the desired fragment (NCCR, early, or late). Each
fragment was then gel extracted and ligated with its counterpart
genome using T4 DNA ligase at a plasmid to fragment ratio of 1:2. All
plasmids were conﬁrmed by DNA sequencing.
Site-directed mutagenesis was performed on both Dik3 and the
TCH2 clone to create and revert to O block polymorphism found in
clinical variants, respectively. The C to T mutation was made in Dik3
using Primer G and its reverse complement and the T to C mutation
was made in TCH2 using Primer H and its reverse complement
(Table 1). Mutations were conﬁrmed by DNA sequencing. The
integrity of the early coding region was also conﬁrmed by DNA
sequencing.Table 1
List of primers used for site-directed mutagenesis and SOEing PCRa.
Primer Sequence (5′–3′)
A NCCR early SpeI GGGGAAATCACTAGTCTTTTGCAATTTTTGCAAAAATGG
B NCCR late SacII GACAAGGCCAAGATTCCGCGGCTCGCAAAACATGTC
C Tag PmlI ACACCACCCCCAAAATAACACGTGCTTAAAAGTGGCTTATAC
D NCCR bridge For TAGTAAGGGTGTGGAAGCT
E NCCR bridge Rev CCATGGATTCTTCCCTGTTA
F TCH1 SacII GACAAGGCCAAGATTCCGCGGAGAATTTTAGGGGCGG
G Dik3 C65T GGCCTCAGAAAAAGCTTCCACACCCTTACTAC
H TCH2 T65C GGCCTCAGAAAAAGCCTCCACACCCTTACTAC
a Restriction enzyme sites are underlined and point mutations are shown in bold in
the primer sequence.BKV-NCCRs were ampliﬁed by PCR as previously described
(Vanchiere et al., 2005b) from the urine of a patient with AIDS and
BKV viruria. NCCR amplicons were cloned using the TOPO-TA system
as directed by the manufacturer (Invitrogen, Carlsbad) and then into
the Dun3 backbone. The Dun3 O block, containing the origin of
replication and the SpeI site was added to each NCCR fragment by a
Splicing by Overlap Extension (SOEing) PCR reaction (Horton et al.,
1989). Additionally a SacII site was added to the existing S block of
each NCCR by site directed mutagenesis. However, the SacII site was
added into the truncated R block in the TCH1 clone because the S
block is deleted in this clone. A bridge piece containing the O block
and SpeI site was created by amplifying that region of the Dun3
plasmid using primers D and E. The bridge piece and the NCCR
fragment were combined in a melting and slow cooling reaction using
the program: 5 min at 95 °C; 40 cycles, 30 s each of a gradient from
95 °C to 55 °C; annealing at 68 °C for 5 min. The forward SacII primer
B, or F for clone TCH1, and the reverse SpeI primer A were then added
to the above reaction at 4 nM each and PCR ampliﬁcation was
performed using the program: 3 min 30 s at 94 °C; 30 cycles of 45 s at
94 °C, 1 min at 66 °C, 1 min at 68 °C, annealing and extension at 68 °C
for 7 min. Fragments were then swapped into the Dun3 backbone as
described above. GenBank accession numbers for the NCCRs are as
follows: TCH1, HQ148166; TCH2, HQ148167; TCH3, HQ148168; TCH4,
HQ148169; TCH5, HQ148170.
Transfections
The viral genome was excised from the pBR322 vector by BamHI
(New England Biolabs, Ipswich, MA) digestion and then recirularized
at a concentration of 10 ng/μl using T4 DNA ligase (New England
Biolabs). RPTE cells were seeded into 12 well plates and transfected
with 0.6 μg DNA at 60–70% conﬂuency using TransIT LT-1 transfection
reagent (Mirus Bio, Madison, WI) according to the manufacturer's
instructions with a DNA to transfection reagent ratio of 1:6.
Transfection complexes were removed 18 h post-transfection by
washing once with PBS and adding fresh media.
Southern blotting
Low molecular weight DNA was harvested 4 or 5 days post-
transfection (dpt) by the Hirt protocol (Hirt, 1967). DNA was
linearized by digesting with BamHI or EcoRI and then digested with
DpnI, which cuts only methylated DNA that has not been replicated in
eukaryotic cells (Pipas et al., 1983). The sample was separated on a 1%
agarose gel in 1× TAE buffer (40 mM Tris acetate and 1 mM EDTA, pH
7.8). The gel was washed with depurination solution (0.25 M HCl for
30 min), followed by denaturation solution (0.5 M NaOH, 1.5 M NaCl,
twice for 20 min), followed by neutralization solution (0.5 M Tris–
HCl, pH 7.4, 1.5 M NaCl, twice for 20 min). The gel was transferred
overnight to nylon membrane (Gene Screen Plus, Perkin Elmer) in
20× SSC using capillary transfer. Themembranewaswashed for 5 min
in 6× SSC and exposed to UV light for 2 min, then baked for 2 h at
80 °C to ﬁx the DNA to the membrane. The probe used was a 3239 bp
BKV PvuII fragment excised from pGEM7-TU (another rearranged
variant of BKV) which spans the early region and the NCCR, and was
labeled with the Random Primers DNA Labeling System (Invitrogen).
The membrane was rehydrated in 6× SSC and incubated for 1 h at
68 °C in prehybridization solution (5× SSC, 1× Denhardt's solution, 1%
SDS) with 0.1 mg/ml denatured sheared salmon sperm DNA. The
membrane was incubated overnight at 68 °C in hybridization solution
(5× SSC, 1× Denhardt's solution, 1% SDS) with 0.1 mg/ml denatured
sheared salmon sperm DNA and 1×108 cpm of labeled probe. After
hybridization, the membrane was washed with 2× SSC with 0.1% SDS
twice for 5 min at room temperature followed by 0.2× SSC with 0.1%
SDS twice for 5 min at room temperature and twice for 15 min at
42 °C. The membrane was then rinsed with 2× SSC before being
373N.M. Broekema et al. / Virology 407 (2010) 368–373exposed to ﬁlm. The Southern blot was quantiﬁed using a Typhoon
phosphoimager and Imagequant software (GE).
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